TITLE

Temporal trends (1973—1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope?

AUTHOR(S)
Eloubeidi, Mohamad A.; Mason, Andrew C.; Desmond, Renee A.; El-Serag, Hashem B.
PUB. DATE
July 2003
SOURCE
American Journal of Gastroenterology;Jul2003, Vol. 98 Issue 7, p1627
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
: ObjectiveThe incidence and mortality related to esophageal adenocarcinoma (EAC) has been rising in the United States. Meanwhile, the number of diagnostic and therapeutic procedures has increased in number and improved technologically. However, the impact of these advances on the survival of EAC in clinical practice remains unknown.: MethodsPatients with histologically proven EAC between 1973 and 1997 were identified in registries of the Surveillance, Epidemiology, and End Results database, and analyzed in 5-yr time periods. The observed and relative survival rates were calculated. The joint influence of the time of diagnosis, stage and grade of cancer, demographic features, surgical therapy, and radiotherapy were assessed in Cox proportional hazard survival analyses.: ResultsBetween 1973 and 1997, we identified 4835 patients with EAC. The 1-yr and 5-yr observed survival rates increased from 34% and 5% during 1973–1977 to 44% and 13% during 1993–1997 (p < 0.05). In the Cox survival analysis, the more recent year of diagnosis, early stage of tumor, younger age at presentation, receiving radiotherapy or surgery were independent predictors of reduced risk of mortality. The proportion of patients with in situ EAC and those with local spread increased progressively from 0.3% and 17.7% in 1973–1977 to 2.3% and 25.3%, respectively, in 1993–1997 (p < 0.05). The proportion of patients receiving radiation therapy either before or after surgery has increased from 7% in 1973–1977 to 16% in 1993–1997 (p < 0.05).: ConclusionsThe short- and long-term survival of patients with EAC has improved slightly in the United States over the past 25 yr. Some of the improvement may be related to an increase in the number of younger patients, and in cases with in situ and localized cancers. However, the overall survival of patients with EAC remains dismal.
ACCESSION #
10234259

 

Related Articles

  • Long-term Follow-up of Barrett's High-Grade Dysplasia. Weston, Allan P.; Sharma, Prateek; Topalovski, Margaretia; Richards, Robert; Cherian, Rachel; Dixon, Anita // American Journal of Gastroenterology;Aug2000, Vol. 95 Issue 8, p1888 

    OBJECTIVE: The management of Barrett's high-grade dysplasia (HGD) remains controversial. The aims of this study were to evaluate prospectively the outcome of unifocal HGD (uHGD) in patients with Barrett's esophagus, and to determine demographic and endoscopic features predictive of progression...

  • Neuroendocrine Carcinoma Arising in Barrett's Esophagus. Slavin, John; Pitson, Graham; Dowling, John P. // International Journal of Surgical Pathology;Jul1994, Vol. 2 Issue 1, p43 

    There is a well-established association between Barrett's esophagus and esophageal adenocarcinoma. Primary esophageal neuroendocrine carcinoma is a rare tumor and has not previously been reported in association with Barrett's esophagus. We report such a case with immunohistochemical and electron...

  • Barrett's Esophagus With High Grade Dysplasia: Surgical Results and Long-Term Outcome— An Update Tseng, Elaine E.; Wu, T.T.; Yeo, Charles J.; Heitmiller, Richard F. // Journal of Gastrointestinal Surgery;Feb2003, Vol. 7 Issue 2, p164 

    We updated our surgical results and long-term outcome for prophylactic esophagectomy in patients with Barrett''s esophagus and high-grade dysplasia (HGD) and determined the incidence of occult adenocarcinoma. Sixty consecutive patients with HGD who underwent esophagectomy had pre- and...

  • Screening and Surveillance for Barrett Esophagus in High-Risk Groups: A Cost-Utility Analysis. Inadomi, John M.; Sampliner, Richard; Lagergren, Jesper; Lieberman, David; Fendrick, Mark; Vakil, Nimish // Annals of Internal Medicine;2/4/2003, Vol. 138 Issue 3, p176 

    Determines the cost-effectiveness of screening for Barrett esophagus in patients with gastroesophageal reflux disease (GERD). Use of a decision analytic model; Study of 50-year-old white men with symptoms of GERD; Cost-effectiveness of screening 50-year-old men with symptoms of GERD to detect...

  • Prospective Long-Term Endoscopic and Histological Follow-Up of Short Segment Barrett's Esophagus: Comparison with Traditional Long Segment Barrett's Esophagus. Weston, Allan P.; Krmpotich, Philip T.; Cherian, Rachel; Dixon, Anita; Topalosvki, Margaretia // American Journal of Gastroenterology;Mar1997, Vol. 92 Issue 3, p407 

    Objectives: Barrett's esophagus is associated with adenocarcinoma of the cardia and esophagus, regardless of its extent. The aim of this study was to compare the prevalence and incidence of dysplasia and adenocarcinoma in short segment and traditional long segment Barrett's esophagus. Methods:...

  • Adenocarcinoma of the Esophagus and Barrett's Esophagus: A Population-Based Study. Bytzer, Peter; Christensen, Peer Brehm; Damkier, Per; Vinding, Kirsten; Seersholm, Niels // American Journal of Gastroenterology;Jan1999, Vol. 94 Issue 1, p86 

    Objective: We described incidence rates of esophageal adenocarcinoma in Denmark in a 20-yr period and determined the proportion of patients diagnosed with esophageal adenocarcinoma who had a previous diagnosis of Barrett's esophagus, making them potential candidates for endoscopic surveillance....

  • Endoscopy for Barrett's Esophagus and Esophageal Adenocarcinoma. Shaheen, Nicholas // American Family Physician;5/1/2004, Vol. 69 Issue 9, p2060 

    Focuses on the endoscopic screening for Barrett's esophagus and esophageal adenocarcinoma in patients with reflux symptoms. Relation of gastroesophageal reflux disease with cancer; Benefits from medical screening tests; Prevalence of Barrett's esophagus in the U.S.

  • Screening for Barrett's Esophagus. DeVault, Kenneth R. // American Family Physician;5/1/2004, Vol. 69 Issue 9, p2061 

    Focuses on the endoscopic screening of Barrett's esophagus. Association between esophageal adenocarcinoma and gastroesophageal reflux disease; Biopsy of esophageal mucosa required for the diagnosis of Barrett's esophagus; Health risk of the routine biopsy of a squamocolumnar junction.

  • The Development of Dysplasia and Adenocarcinoma During Endoscopic Surveillance of Barrett's Esophagus. Katz, David; Rothstein, Richard; Schned, Alan; Dunn, John; Seaver, Kim; Antonioli, Donald // American Journal of Gastroenterology;Apr1998, Vol. 93 Issue 4, p536 

    Objective: Periodic endoscopic surveillance is generally recommended for patients with Barrett's esophagus. The optimal follow-up strategy for uncomplicated Barrett's esophagus is controversial, in part because of limited data on the rate of neoplastic progression (through the sequence of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics